2,0
8 mar 2016
Ex dipendente, più di 5 anni
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Novel technology, dedicated colleagues. Excellent customer base among the top Pharma companies around the world. Excellent benefits.
Svantaggi
After the takeover by Accelrys, the future development of the SmartLab enterprise platform was abandoned, as well as many of the employees who helped build the ELN business.